Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
VANCOUVER, BC - April 19, 2017 (Investorideas.com Newswire)
Lotus Ventures Inc. (CNSX: J) is pleased to report that its activities to
obtain Licensed Producer (LP) status under the Health Canada, Access To
Cannabis For Medical Purposes Regulations (ACMPR) has moved forward and we are
poised to begin construction of the first facility in 2017.
Lotus has received approval for the necessary building permit
for its proto-type facility from Spallumcheen Township near Armstrong BC. We
have received a binding financial commitment to fund the two-stage
construction, previously announced on January 30, 2017 and have received
further information that Lotus Ventures Inc. has well advanced along in the
approval process and expects to receive an affirmation confirmation from Health
Canada to commence building this year. We have also created a community
contribution profile which highlights our creation of 60 - 70 permanent jobs
from the initial $18 million investment plan in the North Okanagan region.
Health Canada has increased its budget and staffing, which will
increase the speed at which it issues affirmation confirmations and processes
LP applications. The Federal Government has issued legislation in favor of LP's
being the permitted producers in the adult recreation legal market to commence
July 1, 2018.
These announcements are material milestones for Lotus Ventures
becoming an important market participant in the rapidly-developing Canadian
regulated market for both medical and adult recreational use markets. We anticipate
events developing more rapidly, in the near future, and will keep our
shareholders informed as we move forward with our business plans.
ON BEHALF OF THE BOARD
Lotus Ventures Inc.
Dale McClanaghan, President and CEO
The Canadian Securities Exchange does not accept responsibility
for the adequacy or accuracy of this release.
This news is published on the Investorideas.com Newswire - a
global digital news source for investors and business leaders
Disclaimer/Disclosure:Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info:http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
#Cannabis
Stock News Just in Time for 4/20; SinglePoint Inc. (OTC: $SING) Added to
#420CannabisInvestorIdeas Directory
April 19, 2017 (Investorideas.com
Newswire) Cannabis stock news for 4/20 - www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks, and its
affiliated directorywww.420cannabisinvestorideas.comannounce the most recent addition to the 420 Cannabis Investor Ideas of
2017; SinglePoint Inc. (OTC:SING), an acquisition based company focused in the
cannabis space. Most recently SinglePoint acquired a stake in Convectium, a
profitable company supplying hardware solutions to the cannabis industry.
The 420 Cannabis Investor Ideas of
2017 will feature a maximum of 420 companies to be showcased for a year.
Investorideas.com will create a free downloadable PDF of the full directory for
investors to use as a reference and due diligence tool.
SinglePoint's(OTC: SING)
flagship product is a best-in-class mobile commerce and communications platform that
enables dispensaries to market to consumers through SMS messaging and accept
electronic payments. By building a network of dispensaries leveraging its SMS
marketing technology, the company is positioning itself to take advantage of a
vast opportunity in the payments space when federal guidelines surrounding
cannabis banking are finalized. The company is focused on providing business
solutions to the enterprises rather than cultivation and consumers. In a market
that is so heavily regulated by the government SinglePoint's hands-off approach
offers investors an opportunity to diversify their portfolio.
SinglePoint (OTC: SING)
recently revamped their corporate website, aimed at providing investors easier
access and transparency to the company's initiatives. While this site will be
corporate focused, SinglePoint will continue to offer solutions to the cannabis
industry through its subsidiarySingleSeed.com.
New Frontier Data(also featured on
the 420 Cannabis Investor Ideas Directory), the authority in business
intelligence for the cannabis industry, forecasts the legal cannabis market to
grow to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 16%.
Their Cannabis Industry Annual Report
"2017 Legal Marijuana Outlook", also found that if all the states
which are currently legal continue their projected growth, they could generate
$2.3 billion in state tax revenue from retail sales by 2020 and the U.S.
Cannabis Market will Create 283,422 Jobs by 2020.
With all this money at stake its
growth opportunity has been compared to the beginnings of the internet. But
with all the opportunity comes the risk as well. The directory is meant to be
one of several tools investors can use as a go-to resource to navigate the
sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place
for global investors, featuring news, stock directories, video, podcasts,
company profiles, interviews and more in leading sectors.
Disclaimer:This directory is not a recommendation to buy or sell securities or
products or services Investorideas.com charges a fee for placement. The
directory is not an endorsement or recommendation but meant to be an investor
resource/ due diligence tool.
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp. Disclosure:
Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee
of Up to $1000 to be featured on the directory
Additional info regarding BC
Residents and global Investors: Effective September 15 2008 - all BC investors
should review all OTC and Pink sheet listed companies for adherence in new
disclosure filings and filing appropriate documents with Sedar. Read for more
info:http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
4/20 News Alert; Directory of Canadian, US and
global Cannabis and Hemp Stocks Now Available to Retail Investors
Point Roberts, WA, Delta BC - April 19, 2017 -
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces for 4/20 that its cannabis /hemp
stock directory is now
available to retail investors.
The directory, which features Canadian listed, US
listed and global cannabis stocks is available to Investors as part of the
annual membership or in a PDF.
22nd
Century Group Inc. (NYSE MKT:XXII) is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of nicotine in
tobacco plants and the level of cannabinoids in cannabis plants through genetic
engineering and plant breeding. The Company’s primary mission is to reduce the
harm caused by smoking. 22nd Century currently owns or exclusively controls
more than 200 issued patents and more than 50 pending patent applications
around the world. The Company’s strong IP position led to a licensing agreement
with British American Tobacco (“BAT”), the world’s second largest tobacco
company.
3DX Industries Inc. (OTC: DDDX) is focused on the additive metal
manufacturing segment within the manufacturing industry. 3DX has the capability
of manufacturing a wide variety of products using its 3D metal printing system,
3D composite printing as well as more traditional methods of precision
manufacturing. 3DX offers additive and subtractive manufacturing options as
well as product design, engineering and assembly services to its
customers. Cannabis: Has completed the
development and design of a new and innovative product used for recovering
excess heat from high energy grow lights.The
part was designed specifically for the legalized cannabis markets including
medical marijuana using the company's 3D Metal printing -- Binder Additive
manufacturing process and is expected to be installed in select licensed facilities
for real world testing in the coming months.
ABATTIS BIOCEUTICALS (OTC:ATTBF) is a specialty biotechnology company with
capabilities through its wholly owned subsidiaries of cultivating, licensing
and marketing proprietary ingredients, bio-similar compounds, patented
equipment and consulting services to medicinal markets in North America. The
Company is positioned to capitalize on the fast growing trend toward marijuana
legalization in the United States and for medicinal use in Canada and
international jurisdictions, by supplying and partnering with companies to
employ its mass cultivation systems, extraction equipment/technology, and
strategic marketing support to licensed growers. The Company also has an
extensive pipeline of high-quality products and intellectual property for the
rapidly expanding botanical drug market. We follow strict standard operating
protocols, and adhere to the applicable laws of Canada and foreign
jurisdictions.
Acology
Inc (OTC:ACOL) markets and sells the TSOS
Container™ (The Science of Storage).This container is the first-ever FDA
approved polypropylene air-tight, water-tight, smell-proof delivery and storage
container with a built-in grinder. It is manufactured from medical-grade No. 5
polypropylene resin, which is non-porous and non-leaching. These containers are
portable and affordable. he Medtainer™ allows patients to store, grind and pour
a variety of medications, including pills and all sizes and solidity, herbal
medications and teas and even coffee and spices! The Medtainer™ can be ordered
in with a certified child-resistant cap. Each Medtainer™ is water-proof and
smell proof. Caregivers who are responsible for ensuring their patients
medication regimens are universally pleased with the how easy and effective the
Medtainer™ grind medications. It is an excellent solution for patients with
dysphasia due to cognitive disorders or brain injuries, are in hospice or
palliative situations and for anyone who would rather not swallow whole pills.
The MedTainer™ was originally developed for geriatric and pediatric patients
who had difficulty swallowing pills or needed an effective alternative to
costly name-brand medications. The MedTainer™ has been sold and is being
successfully used throughout the United States, Canada, Mexico and South
America and Europe. Our association with the Medical Marijuana community was an
unexpected windfall that has given Acology, Inc. the necessary funding to
expand into the growing hospice and palliative care markets, and to help
countless patients who are living at home or in small home-like settings and
need help swallowing pills.
Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide
innovative healthcare products, holistic pain management solutions, and enhance
the footprint in the evolving legal cannabis business. Advantis acquires
ownership in developing companies that work within the nutraceutical and the
alternative health care industries; consulting with these organizations to
improve their product lines, expand their distribution channels through
internal partnership agreements, and heighten brand value.
AeroGrow International, Inc. (OTC:AERO)
Headquartered in Boulder, Colorado, AeroGrow
International, Inc. is the leader in the rapidly growing indoor gardening category.
AeroGardens allow anyone to grow farmer's market fresh herbs, salad greens,
tomatoes, chili peppers, flowers and more, indoors, year-round, so simply and
easily that no green thumb is required. With an AeroGarden... you can grow
anything! In April 2013, AeroGrow entered into a strategic partnership with
Scotts Miracle-Gro to continue to expand the indoor gardening market.
AFFINOR GROWERS (CSE:AFI; OTC:RSSFF) is focused
on growing high quality crops such as romaine lettuce, spinach, strawberries
and high quality medical Marijuana. Affinor is committed to becoming a
pre-eminent grower, using exclusive vertical farming techniques.
Agritek Holdings Inc
(OTC:AGTK) a fully reporting Company and pioneer within the
medicinal marijuana space provides innovative patient and agricultural
solutions seeks to be the leader in Compassionate Care Technology for the
medicinal marijuana industry. Agritek Holdings provides real estate management
and health and wellness product lines through its wholly-owned subsidiary,
Agritek Holdings Inc. Agritek Holdings
Inc. does not directly grow, harvest, or distribute or sell cannabis or any
substances that violate United States law or the Controlled Substances Act, nor
does it intend to do so in the future.
ALGAE DYNAMICS CORP (OTCQB: ADYNF)is currently engaged in the
commercialization of our proprietary BioSilo® algae cultivation system for the
high volume, low cost production of pure contaminant-free algae biomass. This
biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all
of which are in demand by the growing multibillion dollar food/beverage and
health care sectors. Our integrated BioSilo® manufacturing system provides low
cost algae biomass production with modest capital cost requirements compared to
conventional approaches. Furthermore, our "controlled outcomes"
technology provides ultra-high purity algae biomass, differentiating it from
other producers in the market. Following completion of a commercial-scale
production facility we intend to produce algae biomass for sale into the
functional additive and supplement markets, focusing on Chlorella and Omega-3
oil.
Alliance Growers Corp. (CSE:ACG)
is a cannabis company dedicated to
building shareholder value through its 4 Pillars business strategy. The company
was incorporated in 2014 and is publicly traded on the CSE under the symbol
ACG. The company’s head office is in Vancouver, BC and its interest in a
marijuana production facility in Kelowna, BC.
The complete marijuana/hemp stock list available for purchase in a PDF
format:
Investorideas.com tracks companies in high profile
trading sectors and makes ongoing additions to its stock directories for each
sector. Listing for the stock directories include companies on the
TSX, OTC, NYSE, NASDAQ and global stock exchanges.
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review.http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company
profiles, interviews and more in leading sectors.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure SING is a paid featured profile company for PR and news and
SING and ADYNF are paid featured companies on the 420 directory www.420cannabisinvestorideas.com
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
#Cannabis Stock News: Jenex (TSXV: $JEN.H) to
Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the
Zika and West Nile Viruses
Toronto, Ontario - April 18, 2017 (Newsfile Corp.)
(Investorideas.com Newswire) NOT FOR DISSEMINATION OR DISTRIBUTION IN THE
UNITED STATES- The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the
"Company"), a progressive medical device technology company, would
like to report the testing of a topical cannabidiol ("CBD") oil from
hemp with Jenex's platform technology, including Jenex's TherOZap™ device. The
topical cannabidiol oil will be included in the lab tests, to be conducted
through University Health Network and coordinated through Techna Institute at
UHN located in Toronto, Ontario, to determine the effectiveness at inactivating
both the Zika and West Nile viruses as previously announced on April 7th, 2017.
There is a growing body of clinical research demonstrating CBD's
potential therapeutic uses against viruses. The clinical research is revealing
and is demonstrating that CBD can have positive health effects as CBD increases
nitric oxide levels in the human body which may prove to be an effective
treatment to combat viral infections such as the Zika and West Nile viruses.
There are high levels of CBD in hemp but almost no tetrahydrocannabinol (THC),
the psychoactive component that is prevalent in cannabis.
Jenex will work with partners in the medical marijuana industry
to license a topical CBD oil or working through formulators Jenex will create
its own topical CBD oil to be used with the TherOZap™ device. Several natural
health products in topical formulations with unique delivery systems could be
developed.
Rob Fia, CEO commented:
"We are excited to test our platform technology, including
our TherOZap™ device, with a topical cannabidiol oil. Our platform technology
combined with a unique CBD topical delivery system may prove beneficial in
potentially combating the increasingly troublesome Zika virus problem now
affecting many parts of the world."
RISKS AND UNCERTAINTIES INHERENT TO THE MEDICAL MARIJUANA
BUSINESS
The Company plans to continue its principal business of
developing its consumer product platform technology. The Company's pursuit of
the use of hemp oil with CBD is supplementary to the consumer product platform
technology business it is currently engaged in. The board of directors have
approved the Company's testing of hemp oil with CBD and to the Company's
knowledge, this is the only approval required for the Company's pursuit of opportunities
to test hemp oil with CBD with its platform technology. There are risks and
uncertainties inherent to the medical marijuana businesses and it should be
noted that the Company does not intend to acquire a medical marijuana license.
Jenex received a Class II medical device status from the FDA for
its platform technology that is indicated for the relief of the pain, itch, and
inflammation from over 20,000 different insect stings and bites, (including
bees, wasps, hornets, mosquitoes, black flies and jellyfish). Jenex received
approval for the above claims from FDA (United States) in 1997.
Jenex continues to further develop, and explore other
applications, for its platform technology. If you would like to stay informed
on the development of TherOZap™ please visitwww.therozap.com.
About
Jenex:
Jenex is a progressive medical device technology company focused
on providing consumers with quality medical devices that address their
dermatological needs. Clear and healthy skin for all is at the core of Jenex's
philosophy as is the belief that such outcomes should not be a privilege for
only those who can afford costly procedures and treatments. The Company's
breakthrough proprietary technology delivers effective, non-invasive and pain
free skin care. The Jenex Corporation trades on the NEX (NEX: JEN.H). For more
information visit:www.thejenexcorporation.comorwww.therozap.com.
About
Techna Institute:
Techna is an institute of the University Health Network, in collaboration
with the University of Toronto, focused on the accelerated development and
exploitation of technology for improved health. Techna is designed to shorten
the time interval from technology discovery and development to application for
the benefit of patients and the health care system. It also stimulates and
facilitates the innovation cycle through a continuum of clinically driven
innovation, technology & process development, and translational research.
For more information visit:technainstitute.com.
About
University Health Network:
University Health Network (UHN) is a major landmark in Canada's
healthcare system and a teaching partner of the University of Toronto. UHN
consists of Toronto General and Toronto Western Hospitals, the Princess
Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener
Institute for Education at UHN. The scope of research and complexity of cases
at University Health Network has made it a national and international source
for discovery, education and patient care. It has the largest hospital-based
research program in Canada, with major research in cardiology, transplantation,
neurosciences, oncology, surgical innovation, infectious diseases, genomic
medicine and rehabilitation medicine. For more information visit:www.uhn.ca.
FORWARD LOOKING STATEMENTS
Certain statements in this news release constitute
"forward-looking" statements. These statements relate to future
events or the Company's future performance and include tests involving the
Company's TherOZap™ technology and CBD oil from hemp as described in the news
release. All such statements involve substantial known and unknown risks,
uncertainties and other factors which may cause the actual results to vary from
those expressed or implied by such forward-looking statements. In addition to
other risks, the Company's tests involving TherOZap™ and CBD oil from hemp may
prove to be unsuccessful against the Zika or West Nile viruses and the Company
may be unable to complete the consumer product TherOZap™ technology. Further,
the Company may not complete the tests on the schedule it expects as described
in this news release or attract capital for marketing to ramp up sales or
establish recurring revenue in the future to generate cash flow for the
Company. Forward-looking statements involve significant risks and
uncertainties, they should not be read as guarantees of future performance or
results, and they will not necessarily be accurate indications of whether or
not such results will be achieved. Actual results could differ materially from
those anticipated due to a number of factors and risks. Although the
forward-looking statements contained in this news release are based upon what management
of the Company believes are reasonable assumptions on the date of this news
release, the Company cannot assure investors that actual results will be
consistent with these forward-looking statements. The forward-looking
statements contained in this press release are made as of the date hereof and
the Company disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information, future
events or otherwise, except as required under applicable securities
regulations.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this press release.
For
further information please contact:
The Jenex Corporation
Rob Fia
CEO & Chairman
rfia@thejenexcorporation.com
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
In Celebration of 4/20, The Marijuana Show
Launches "Light It Up" Album to help Fund Cannabis Nonprofits: NCIA
and CannaMoms
The Amazon TV Show Pledges to Help Push the
Conversation of Legalization Into the Future with the Light It Up Indica +
Sativa Album
Denver, CO. - April 18, 2017 (Investorideas.com Newswire) With
the annual 4/20 cannabis holiday just two days away, The Marijuana Show, (TMS)
an Amazon TV series dubbed "The Shark Tank for Ganjapreneurs," has
released a curated digital album to generate donation funding for NCIA and
CannaMoms, two nonprofits pushing towards national cannabis legalization.
"Light It Up: an Indica + Sativa Playlist" is
available now for $9.49 at TheMarijuanaShow.com and Amazon. Comprised of
multiple music genres, the tracks are organized into two categories one for
upbeat (Sativa) moments and the other for down-tempo (Indica) moods, together
providing a way for the canna-community to not only acquire new tunes but to
also help push national cannabis legalization.
"CannaMoms and NCIA are very dear to us," said TMS
co-creator and host Karen Paull. "We are legalize it advocates, love
connecting people and this album is a great way to generate funds, allow the
musicians to reach new listeners and also provide a way for consumers to join
the fight while scooping up some new tunes," added Paull.
A portion of proceeds will aid NCIA, the only national trade
association advancing the interests of the legitimate and responsible cannabis
industry organization pioneering the legalization and decriminalization of
cannabis, in addition to CannaMoms, an organization of mothers advocating for
the right and option to utilize cbd and/or cannabis in the care of their own
critically-ill or special needs children and was co-produced by Tornadic Entertainment
LLC and The Marijuana Show.
The album will also be available at Denver's hottest new event,
420 On The Block, at The Marijuana Show's exhibitor booth. The booth will also
have special order rolling papers, an additional way to donate to NCIA and Cannamoms,
plus a photo booth where interested Ganjapreneurs can submit a two minute video
pitch to the judges and possibly secure a spot on Season 3 of The Marijuana
Show.
"420
On The Block is an elevated experience where we can come together to celebrate
cannabis through music, art, comedy and community in a safe, regulated space.
As pioneers of the industry and cannabis-related media, The Marijuana Show felt
like a natural partnership for the celebration," said Adrian Zelski,
founder of New Earth Muziq.
As The Marijuana Show gears up for Season 3, so too are hundreds
of hopeful cannabis entrepreneurs all seeking a chance to garner funding from
the $20 million private equity fund titled, the "High Finance Fund."
The
Marijuana Show
The Marijuana Show is the first-ever reality show about
investing in Cannabis, created and produced by Wendy Robbins and Karen Paull.
#MJRealityShow has connected wanna-be ganjapreneurs with more than $18 million
in financing with more than $20 million available for Season Three. The
Marijuana Show is produced by parent company Green Equity Media, LLC, For more
information, visitwww.themarijuanashow.com, find us on Twitter; Facebook;
Instagram and use #MJRealityShow #LegalizeIt to join the conversation.
Contact:
Thomas Giordonello
845.514.6626
thomas@tgpublicrelations.com)
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
